Skip to main content
SpringerLink
Log in

Actual clinical use of gadolinium-chelates for non-MRI applications

  • Contrast media
  • Published:
European Radiology Aims and scope Submit manuscript

Abstract

For many years, alternatives to iodinated X-ray contrast media have been sought. Of the contrast media investigated to date, only CO2 and the gadolinium-chelates have been shown to be viable alternatives for selected X-ray examinations. Therefore, we have reviewed the general literature and that specific for gadopentetate (Magnevist) in particular, since this agent has been studied the most. This review indicates that diagnostic CT examinations can be achieved following the intravenous administration of gadolinium-containing contrast media (CM) for evaluation of aortic abnormalities. Gadolinium-containing CM at the dose approved for MR imaging are not useful for CT evaluation of the abdominal parenchymal organs. Intravenous/intraarterial injections have also been used in a variety of angiographic and interventional procedures. Image quality, however, is generally inferior to iodinated contrast media. Gadolinium-containing CM require no special handling and can be administered by hand injection or via conventional angiographic automated injectors with the same flow rates and pressures as are used with iodinated contrast media. For CT, a peripheral bolus injection of a diluted gadolinium agent (1:1 with saline) of 60–90 ml at 3–5 ml/s is usually performed. Similar to all other gadolinium-chelates, the non-MRI use of gadopentetate (Magnevist) is not approved by regulatory agencies. However, the literature suggests that a dose of 0.3–0.4 mmol/kg b.w. has been safely administered for CT as well as for angiography and interventional procedures intravenously and intraarterially. Even at this dose, though, this results in a relatively small overall volume to be injected, which limits utility somewhat.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Oksendal AN,Hals PA (1993) Biodistribution and toxicity of MR imaging contrast media. J Magn Reson Imaging 3:157–165

    CAS  PubMed  Google Scholar 

  2. Harpur ES, Worah D, Hals PA et al (1993) Preclinical safety assessment and pharmacokinetics of gadodiamide injection, a new magnetic resonance imaging contrast agent. Invest Radiol 28 [Suppl 1]:S28–S43

    Google Scholar 

  3. Thomsen HS, Almen T, Morcos SK (2002) Gadolinium-containing contrast media for radiographic examinations: a position paper. Eur Radiol 12:2600–2605

    PubMed  Google Scholar 

  4. Tweedle MF, Eaton SM, Eckelman WC et al (1988) Comparative chemical structure and pharmacokinetics of MRI contrast agents. Invest Radiol 23 [Suppl 1]:S236–S239

    Google Scholar 

  5. Tweedle MF (1992) Physicochemical properties of gadoteridol and other magnetic resonance contrast agents. Invest Radiol 27 [Suppl. 1]:S2–S6

    Google Scholar 

  6. Nyman U, Elmstahl B, Leander P et al (2002) Are gadolinium-based contrast media really safer than iodinated media for digital subtraction angiography in patients with azotemia? Radiology 223:311–318; discussion 328–329

    PubMed  Google Scholar 

  7. Janon EA (1989) Gadolinium-DTPA: a radiographic contrast agent. Am J Roentgenol 152:1348

    CAS  Google Scholar 

  8. Albrecht T, Dawson P (2000) Gadolinium-DTPA as X-Ray contrast medium in clinical studies. Br J Radiol 73:878–882

    CAS  PubMed  Google Scholar 

  9. Bedair el Said M, El Din Abbas H, Amin M et al (2002) Gadolinium-DTPA: a contrast agent for conventional X-ray and CT examinations; when, why and how? J Med Res Institute 23:1–13

    Google Scholar 

  10. Engelbrecht V, Koch JA, Rassek M (1996) Gadodiamide and gadolinium-DTPA as intravenous media in computed tomography. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 165:24–28

    CAS  PubMed  Google Scholar 

  11. Luboldt W, De SM, von SA et al (1997) Attenuation characteristics and application of gadolinium-DTPA in fast helical computed tomography. Invest Radiol 32:690–695

    Article  CAS  PubMed  Google Scholar 

  12. Quinn AD, O’Hare NJ, Wallis FJ et al (1994) Gd-DTPA: an alternative contrast medium for CT. J Comput Assist Tomogr 18:634–636

    CAS  PubMed  Google Scholar 

  13. Bloem JL,Wondergem J (1989) Gd-DTPA as a contrast agent in CT. Radiology 171:578–579

    CAS  PubMed  Google Scholar 

  14. Chryssidis S, Davies RP,Tie ML (2002) Gadolinium-enhanced computed tomographic aortography. Australas Radiol 46:97–100

    Article  CAS  PubMed  Google Scholar 

  15. Budoff MJ, Lu B,Mao S (2002) Gadolinium-enhanced three-dimensional electron beam coronary angiography. J Comput Assist Tomogr 26:879

    Article  PubMed  Google Scholar 

  16. Pena CS, Kaufman JA, Geller SC et al (1999) Gadopentetate dimeglumine: a possible alternative contrast agent for CT angiography of the aorta. J Comput Assist Tomogr 23:23–24

    Article  CAS  PubMed  Google Scholar 

  17. Gupta AK, Alberico RA, Litwin A et al (2002) Gadopentetate dimeglumine is potentially an alternative contrast agent for three-dimensional computed tomography angiography with multidetector-row helical scanning. J Comput Assist Tomogr 26:869–874

    Article  PubMed  Google Scholar 

  18. Kawano T, Ishijima H, Nakajima T et al (1999) Gd-DTPA: a possible alternative contrast agent for use in CT during intraarterial administration. J Comput Assist Tomogr 23:939–940

    Article  CAS  PubMed  Google Scholar 

  19. Kinno Y, Odagiri K, Andoh K et al (1993) Gadopentetate dimeglumine as an alternative contrast material for use in angiography. Am J Roentgenol 160:1293–1294

    CAS  Google Scholar 

  20. Amar AP, Larsen DW,Teitelbaum GP (2001) Percutaneous carotid angioplasty and stenting with the use of gadolinium in lieu of iodinated contrast medium: technical case report and review of the literature. Neurosurgery 49:1262–1265; discussion 1265–1266

    CAS  PubMed  Google Scholar 

  21. Hammer FD, Goffette PP, Malaise J et al (1999) Gadolinium dimeglumine: an alternative contrast agent for digital subtraction angiography. Eur Radiol 9:128–136

    Article  CAS  PubMed  Google Scholar 

  22. Schild HH, Weber W, Boeck E et al (1994) Gadolinium-DTPA (Magnevist) as contrast medium for arterial DSA. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 160:218–221

    CAS  PubMed  Google Scholar 

  23. Spinosa DJ, Matsumoto AH, Angle JF et al (1998) Use of gadopentetate dimeglumine as a contrast agent for percutaneous transluminal renal angioplasty and stent placement. Kidney Int 53:503–507

    Article  CAS  PubMed  Google Scholar 

  24. Spinosa DJ, Angle JF, Hagspiel KD et al (1998) Co2 and gadopentetate dimeglumine as alternative contrast agents for malfunctioning dialysis grafts and fistulas. Kidney Int 54:945–950

    CAS  PubMed  Google Scholar 

  25. Spinosa DJ, Angle JF, Hartwell GD et al (2002) Gadolinium-based contrast agents in angiography and interventional radiology. Radiol Clin North Am 40:693–710

    PubMed  Google Scholar 

  26. Spinosa DJ, Kaufmann JA,Hartwell GD (2002) Gadolinium chelates in angiography and interventional radiology: a useful alternative to iodinated contrast media for angiography. Radiology 223:319–325; discussion 326–327

    CAS  PubMed  Google Scholar 

  27. Wagner HJ, Kalinowski M, Klose KJ et al (2001) The use of gadolinium chelates for X-ray digital subtraction angiography. Invest Radiol 36:257–265

    Article  CAS  PubMed  Google Scholar 

  28. Dinkel HP, Hoppe H, Baumgartner I et al (2002) Low-osmolar gadodiamide as alternative contrast agent for diagnostic angiography and angiographic interventions in patients with renal insufficiency. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 174:56–61

    Article  CAS  PubMed  Google Scholar 

  29. Kaufman JA, Geller SC, Bazari H et al (1999) Gadolinium-based contrast agents as an alternative at vena cavography in patients with renal insufficiency—early experience. Radiology 212:280–284

    PubMed  Google Scholar 

  30. Schenker MP, Solomon JA,Roberts DA (2001) Gadolinium arteriography complicated by acute pancreatitis and acute renal failure. J Vasc Interv Radiol 12:393

    CAS  PubMed  Google Scholar 

  31. Spinosa DJ, Matsumoto AH, Angle JF et al (1998) Gadolinium-based contrast and carbon dioxide angiography to evaluate renal transplants for vascular causes of renal insufficiency and accelerated hypertension. J Vasc Interv Radiol 9:909–916

    CAS  Google Scholar 

  32. Spinosa DJ, Matsumoto AH, Angle JF et al (1999) Renal insufficiency: usefulness of gadodiamide-enhanced renal angiography to supplement CO2-enhanced renal angiography for diagnosis and percutaneous Treatment. Radiology 210:663–672

    CAS  PubMed  Google Scholar 

  33. Spinosa DJ, Matsumoto AH, Hagspiel KD et al (1999) Gadolinium-based contrast agents in angiography and interventional radiology. Am J Roentgenol 173:1403–1409

    CAS  Google Scholar 

  34. Spinosa DJ, Angle JF, Hagspiel KD et al (2000) Lower extremity arteriography with use of iodinated contrast material or gadodiamide to supplement CO2 angiography in patients with renal insufficiency. J Vasc Interv Radiol 11:35–43

    CAS  PubMed  Google Scholar 

  35. Kaltenborn H, Schadmand S, Beck T et al (1995) Gadolinium-DTPA (Magnevist) as contrast medium for galactography. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 163:457–459

    CAS  PubMed  Google Scholar 

  36. Vehmas T,Markkola AT (1998) Gd-DTPA as an alternative contrast agent in conventional and interventional radiology. Acta Radiol 39:223–226

    PubMed  Google Scholar 

  37. Wenzel R,Leppien A (2000) Gadolinium-myelocisternography for cerebrospinal fluid rhinorrhoea. Neuroradiology 42:874–880

    CAS  PubMed  Google Scholar 

  38. Vehmas T,Tervahartiala P (1996) Gd-DTPA in male urethrography. A case report. Acta Radiol 37:804–805

    CAS  PubMed  Google Scholar 

  39. Spinosa DJ, Pao DG, Matsumoto AH et al (2000) Carbon dioxide and gadodiamide as the contrast agents for diagnosis and embolization of a post-biopsy arteriovenous fistula in a renal allograft. Clin Radiol 55:801–803

    Article  CAS  PubMed  Google Scholar 

  40. Spinosa DJ, Hagspiel KD, Angle JF et al (2000) Gadolinium-based contrast agents in angiography and interventional radiology: uses and techniques. J Vasc Interv Radiol 11:985–990

    CAS  PubMed  Google Scholar 

  41. Spinosa DJ, Angle JF, Hagspiel KD et al (2000) Interventional uroradiologic procedures performed using gadodiamide as an alternative to iodinated contrast material. Cardiovasc Intervent Radiol 23:72–75

    Article  CAS  PubMed  Google Scholar 

  42. Niendorf HP, Haustein J, Cornelius I et al (1991) Safety of gadolinium-DTPA: extended clinical experience. Magn Reson Med 22:222–228; discussion 229–232

    CAS  PubMed  Google Scholar 

  43. Shellock FG, Kanal E (1999) Safety of magnetic resonance imaging contrast agents. J Magn Reson Imaging 10:477–484

    CAS  PubMed  Google Scholar 

  44. Thomsen HS (1997) Frequency of acute adverse events to a non-ionic low-osmolar contrast medium: the effect of verbal interview. Pharmacol Toxicol 80:108–110

    CAS  PubMed  Google Scholar 

  45. Salonen OL (1990) Case of anaphylaxis and four cases of allergic reaction following Gd-DTPA administration. J Comput Assist Tomogr 14:912–913

    CAS  PubMed  Google Scholar 

  46. Arat A, Cekirge HS,Saatci I (2000) Gadodiamide as an alternative contrast medium in cerebral angiography in a patient with sensitivity to iodinated contrast medium. Neuroradiology 42:34–37; discussion 37–39

    Article  CAS  PubMed  Google Scholar 

  47. Erly WK, Zaetta J, Borders GT et al (2000) Gadopentetate dimeglumine as a contrast agent in common carotid arteriography. Am J Neuroradiol 21:964–967

    CAS  PubMed  Google Scholar 

  48. Kaufman JA, Hu S, Geller SC et al (1999) Selective angiography of the common carotid artery with gadopentetate dimeglumine in a patient with renal insufficiency. Am J Roentgenol 172:1613–1614

    CAS  Google Scholar 

  49. Nussbaum ES, Casey SO, Sebring LA et al (2000) Use of gadolinium as an intraarterial contrast agent in digital subtraction angiography of the cervical carotid arteries and intracranial circulation. Technical note. J Neurosurg 92:881–883

    CAS  PubMed  Google Scholar 

  50. Prince MR, Arnoldus C,Frisoli JK (1996) Nephrotoxicity of high-dose gadolinium compared with iodinated contrast. J Magn Reson Imaging 6:162–166

    CAS  PubMed  Google Scholar 

  51. Arsenault TM, King BF, Marsh JWJ et al (1996) Systemic gadolinium toxicity in patients with renal insufficiency and renal failure: retrospective analysis of an initial experience. Mayo Clin Proc 71:1150–1154

    CAS  PubMed  Google Scholar 

  52. Matchett WJ, McFarland DR, Russell DK et al (1996) Azotemia: gadopentetate dimeglumine as contrast agent at digital subtraction angiography. Radiology 201:569–571

    CAS  PubMed  Google Scholar 

  53. Rieger J, Sitter T, Toepfer M et al (2002) Gadolinium as an alternative contrast agent for diagnostic and interventional angiographic procedures in patients with impaired renal function. Nephrol Dial Transplant 17:824–828

    Article  PubMed  Google Scholar 

  54. Hammer FD, Malaise J, Goffette PP et al (2000) Gadolinium dimeglumine: an alternative contrast agent for digital subtraction angiography in patients with renal failure. Transplant Proc 32:432–433

    Article  CAS  PubMed  Google Scholar 

  55. Hatrick AG, Jarosz JM, Irvine AT (1997) Gadopentate dimeglumine as an alternative contrast agent for use in interventional procedures. Clin Radiol 52:948–952

    CAS  PubMed  Google Scholar 

  56. Kaufman JA, Geller SC, Waltman AC (1996) Renal insufficiency: gadopentetate dimeglumine as a radiographic contrast agent during peripheral vascular interventional procedures. Radiology 198:579–581

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiology, University of Bonn, Sigmund-Freud-Strasse 25, 53105, Bonn, Germany

    Holger M. Strunk & H. Schild

Authors
  1. Holger M. Strunk
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. Schild
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Holger M. Strunk.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Strunk, H.M., Schild, H. Actual clinical use of gadolinium-chelates for non-MRI applications. Eur Radiol 14, 1055–1062 (2004). https://doi.org/10.1007/s00330-004-2260-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-004-2260-1

Keywords

Search

Navigation